A society that refuses to age out forgets how to change its mind

I spent the early part of my career threading new hearts into bodies that had waited years for one to open up. Now I watch a different waiting list, and the chart tells a different story. The Meridian Longevity Institute's Earthside clinic holds just over forty thousand names in its coastal cohort. Last quarter the list moved 1.9 percent. At that rate, the person at the back isn't waiting for treatment. They're waiting to be outlived by the wait.

Meanwhile Justice Aurelio Vance, age 130, has declined retirement from the Charter Court for a third term, and the youth assemblies have moved their succession sit-in from the courthouse steps to the clinic doors — the correct diagnosis, I'll grant them. The court and the waitlist are the same line, really: two instruments for deciding who gets the years, and who gets to spend them in charge.

Into this the Institute's ethics board has proposed what it calls 'renewal value' weighting: advance up the list in exchange for vacating a public post. Step down, and you step forward. I understand the appeal. It looks like a market solving two shortages at once with a single elegant trade. I've seen elegant solutions before. They're usually elegant because someone left out the messy part.

Here's the messy part. A therapy that keeps you alive is not a bribe, and the moment we price it like one, we've decided the years are a reward for good institutional behavior rather than a thing a person is owed as a person. We spent a generation building a medicine free of the old cruelty (nobody died in a queue because someone richer or better-connected got the organ first). 'Renewal value' quietly rebuilds that queue and hangs a nicer sign on it.

Consider who would be doing the scoring. Seven of the eleven triage board members have already received tier-one therapy. None have disclosed a place on any waitlist. You don't need to be a cynic to guess how a metric called 'renewal value' fares in the hands of people who've already renewed. You just need to have watched a scoring system meet the people it scores. It gets gamed, and gamed by the fluent — the ones who have a vacatable post to trade and a lawyer to draft the paperwork. The head of household with a title will find the exchange. The forty-thousandth name will find the fine print.

There's a real disease under all this, and I won't wave it away. A body that never replaces its old cells gets cancer. An institution that never turns over gets something with the same growth curve, and we haven't grown the therapy for that one. But the answer to leaders who won't leave isn't to make leaving a purchasable upgrade. That treats power as a chip to cash, and hands the cashier's job to the people already holding the chips.

If we want turnover, we should legislate it — term limits, mandatory succession, the unglamorous plumbing of renewal — and let the therapy be what it is: a treatment, offered by need, not by rank. Otherwise we'll have built a system where the surest way to earn more life is to have spent the last one accumulating something worth trading for it.

Justice Vance is entitled to his heartbeat. Nobody's arguing otherwise. He is not entitled to the docket for as long as he keeps it beating. Different clinic. Different chart.